Gene Techno Sciences Inc.
Basic information
- Head office
- 3-8-3 Nihonbashi Honcho, Chuo-ku, Tokyo
- Chief executive
- Shinya Kuribayashi
- Capital
- 10,000,000 JPY
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2001-03-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| ナノキャリア株式会社 | ||||||||
|
|
||||||||
|
|
||||||||
| 北海道大学創成研究機構 | ||||||||
|
|
||||||||
|
|
||||||||
| Mita Pharmaceutical Co., Ltd. | ||||||||
|
|
||||||||
|
|
||||||||
| GPC Research Institute Inc. | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| SOLA Biosciences LLC | ||||||||
| 長春長生生物科技有限責任公司(長生バイオ) |
Network
History
Established a research institute within the Hokkaido Center of the National Institute of Advanced Industrial Science and Technology to strengthen research and development of bio-new drugs![]()
Received a subsidy from the Ministry of Economy, Trade and Industry for the project "Creation of Movement Disorder Models Due to Cerebellar Dysfunction"![]()
Received joint research and development subsidy for the project "Novel Gene Discovery for Disease Models for Drug Development"![]()
Recognized as "AIST Venture Company (成果創出型)" by the National Institute of Advanced Industrial Science and Technology![]()
Licensed out anti-α9 integrin antibody to Kaken Pharmaceutical Co., Ltd. in the bio-new drug business![]()
Signed a joint development agreement with Fuji Pharmaceutical Co., Ltd. for G-CSF in the biosimilar business![]()
Licensed in G-CSF producing cells and basic production technology from Toa Pharmaceutical Co., Ltd. in the biosimilar business![]()
Obtained manufacturing and sales approval for G-CSF jointly developed with Fuji Pharmaceutical Co., Ltd. (launched in May 2013)![]()
Entered capital and business alliance with Itochu Chemical Frontier Co., Ltd. in the biosimilar business![]()
Signed a joint development agreement with Sanwa Chemical Research Institute Co., Ltd. for Darbepoetin alpha in the biosimilar business![]()
Aiming to commercialize nucleic acid drug development platform, signed a joint nucleic acid business agreement with Gene Design Inc.![]()
Signed a capital and business alliance with ORTHOREBIRTH Inc. for research and development of artificial bones.![]()
Daidō Inko Co., Ltd. participates in capital with a view to collaboration in medical and healthcare-related businesses.![]()
Signed a basic agreement on joint development and sales of biosimilars in the cancer treatment field with Mochida Pharmaceutical Co., Ltd.![]()
Signed a basic agreement on capital and business alliance for joint development and sales of ophthalmic biosimilars with Senju Pharmaceutical Co., Ltd.![]()
Concluded a tender offer for our common stock and a capital and business alliance agreement with Noritz Steel Group.![]()
Signed a joint business development agreement for ophthalmic biosimilars with Senju Pharmaceutical Co., Ltd.![]()
Signed a basic agreement on commercialization of biosimilars in the Chinese market with Changchun Changsheng Biological Technology Co., Ltd. (Changsheng Bio).![]()
Contracted a capital and business alliance with Japan Regenerative Medicine Inc. (JRM) for regenerative medicine utilizing cardiac stem cells.![]()
Signed a joint business development agreement for biosimilars in the cancer treatment field with Mochida Pharmaceutical Co., Ltd.![]()
Signed a capital and business alliance agreement with Itochu Chemical Frontier Inc. for new biosimilar development.![]()
Signed a joint research agreement with Chromocenter Inc. to establish foundational technology for high-producing cell line construction.![]()
Signed a joint research agreement with SOLA Biosciences, LLC in the United States for establishing foundational technology for high-producing cell line construction.![]()
Started commissioned research with GPC Research Institute Inc. for high-producing cell line construction.![]()
Joint research and development agreement with Orthorebirth Inc. to create treatments for cleft lip and palate![]()
News
There is no news.